サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1744962

大動脈弁の世界市場

Aortic Valves

出版日
ページ情報
英文 268 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
大動脈弁の世界市場
出版日: 2025年06月06日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 268 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

大動脈弁の世界市場は2030年までに98億米ドルに達する見込み

2024年に61億米ドルと推定される大動脈弁の世界市場は、2024年から2030年にかけてCAGR 8.2%で成長し、2030年には98億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである機械式バルブは、CAGR7.1％を記録し、分析期間終了までに58億米ドルに達すると予測されます。生物学的バルブの成長率は、分析期間中CAGR 10.1％と推定されます。

米国市場は17億米ドルと推定、中国はCAGR12.6％で成長予測

米国の大動脈弁市場は、2024年に17億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに21億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは12.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.2%と7.8%と予測されています。欧州では、ドイツがCAGR 5.5%で成長すると予測されています。

世界の大動脈弁市場- 主要動向と促進要因のまとめ

大動脈弁が高齢化社会における心臓構造疾患管理の中心である理由

大動脈弁は、左心室から大動脈への一方向の血流を調節する上で重要な役割を担っており、その機能不全（典型的には狭窄や逆流）は、心臓の重大な罹患率や死亡率につながります。外科的あるいは経カテーテル的アプローチによる大動脈弁置換術（AVR）は、構造的心疾患、特に変性弁膜症を有する高齢患者における主要な治療法となっています。大動脈弁狭窄症の世界の負担が人口動態の高齢化と並行して増加する中、大動脈弁は心機能を回復し、症状を緩和し、生存率を向上させる救命インプラントとしてますます注目されています。

歴史的には、外科的大動脈弁置換術（SAVR）が標準的な治療法であり、心肺バイパスを用いた開心術が必要でした。しかし、低侵襲的アプローチである経カテーテル的大動脈弁置換術（TAVR）の出現は、治療パラダイムを一変させ、以前は手術不能あるいは手術リスクが高いとみなされていた患者へのアクセスを拡大しました。TAVRの使用はその後、中リスク群や低リスク群にも拡大し、より広範な患者コホートにおいて第一選択治療としての役割を強めています。この変化は、適切な候補者においてSAVRと同等かそれ以上の転帰を示す良好な臨床試験データによって促進されています。

狭窄症にとどまらず、大動脈弁インターベンションは、二尖弁疾患の管理、変性した生体弁に対するバルブインバルブ手技、および複数の弁インターベンションを必要とする複合弁膜症の管理において、地歩を固めつつあります。心不全、石灰沈着性弁変性の有病率の増加、および無症候性患者のスクリーニングの増加は、手技件数をさらに増加させています。平均寿命が延び、心血管系疾患が世界の健康上の優先事項であり続ける中、大動脈弁置換術は現代の心臓病学において重要な治療であり続けています。

弁の性能と患者の転帰を向上させる機器の革新と手技技術はどのように進歩しているのでしょうか？

弁の設計における革新は、外科的弁と経カテーテル弁の両方の血行力学的性能、耐久性、および移植性を向上させています。ウシやブタの心膜組織から作られた生体弁は、現在では抗石灰化剤で処理され、免疫反応を抑え寿命を延ばすために柔軟なフレームに取り付けられています。新世代のTAVRシステムには、再位置決めや回収が可能な機能、より薄型の送達カテーテル、高度に石灰化した大動脈基部や二尖大動脈基部のような解剖学的に困難な症例でも確実に固定するための強化された橈骨強度が備わっています。

特にマルチディテクターCTや3D心エコーなどの術前画像診断の進歩により、より正確な患者選択、環状部のサイジング、手技計画が可能になりました。画像診断とデジタルナビゲーションプラットフォームおよびリアルタイムの透視ガイダンスの統合は、傍弁漏、血管損傷、および伝導障害を最小化しました。さらに、脳塞栓防止装置や意識下鎮静プロトコールなどの手技中の技術革新は、安全性プロファイルを改善し、回復時間の短縮を可能にしています。

耐久性は、特に若年で低リスクの患者がTAVRを受ける際に、技術革新の中心的な焦点であり続けています。現在進行中の臨床試験では、リーフレットの寿命、弁の構造的劣化、および長期的な採用を支援するための血栓形成性が評価されています。ポリマーベースの弁尖デザイン、組織工学的足場、抗血栓性コーティングは、現在の生体補綴の限界を超えて弁の寿命を延ばすために研究されています。一方、バルブ・イン・バルブ手技の標準化、小さな弁輪での血行動態の最適化、ペースメーカー依存の低減への取り組みが、デバイスの進化における次のフロンティアを押し進めつつあります。

大動脈弁インターベンションの需要を促進している患者セグメントと地域市場は？

大動脈弁置換術の主な推進力は、症候性重症大動脈弁狭窄症の高齢患者であり、特に診断アクセス、手技インフラ、償還モデルが確立している北米と西欧です。しかし、心エコー検査によるスクリーニングの普及と心臓弁膜症に対する意識の高まりにより、無症候性患者や中等度リスクのグループでも紹介が拡大しています。TAVRは、虚弱な患者、心臓手術の既往のある患者、開胸手術のリスクを増大させる解剖学的複雑性を有する患者にますます好まれています。

特に、診断時の平均年齢が低い市場や、償還の制約からSAVRが既定路線となっている市場では、若年患者や二尖弁患者が重要な焦点として浮上しています。また、生体弁インプラントの第一波が退行し始める中、バルブ・イン・バルブの分野も急成長しています。これは、再治療における安全性と有効性のエビデンスの高まりに支えられ、TAVRの再手術に対する新たな需要を生み出しています。

地域別では、北米が最大の市場シェアを占め、次いで欧州が高い手術件数、高度なヘルスケア・インフラ、確立されたトレーニング・エコシステムに牽引されています。アジア太平洋は、医療アクセスの拡大、心臓弁膜症に対する意識の高まり、中国、インド、日本、東南アジアの民間心臓血管センターの急成長により、最も急速に成長している地域です。一方、ラテンアメリカ、中東・アフリカの一部での採用は、官民パートナーシップ、医療ツーリズム、三次心臓血管治療インフラへの投資の増加によって支えられています。

規制の新興国市場開発、バリューベース医療モデル、臨床エビデンスは市場拡大にどのような影響を与えているか？

大動脈弁装置の規制状況は急速に進化しており、当局は優先審査、画期的指定、世界な臨床データへの依存を通じて、TAVRシステムの承認経路を加速させています。FDAやEMAなどの機関は、機器の適応を高リスク患者から中・低リスク患者へと拡大し、より広範な手技適格性と保険適用を推進しています。米国のTVTや欧州のNOTIONのような市販後サーベイランスやレジストリは、継続的な償還やガイドラインへの組み込みをサポートする長期的なアウトカムデータを提供しています。

ヘルスケアシステムが価値ベースのモデルを採用するにつれて、費用対効果とQOLの向上は技術採用にとって極めて重要になってきています。数多くの医療経済研究が、TAVRは初期費用が高いにもかかわらず、再入院の減少、機能的転帰の改善、対象集団における死亡率の低下を通じて長期的な価値を提供することを示しています。病院は、手技の成功率、再介入のリスク、および多職種からなる心臓専門チームにおける進化する治療プロトコールとの適合性に基づいて、弁プラットフォームを選択するようになってきています。

ESC、AHA/ACC、JCSなどの学会の臨床ガイドラインは、TAVRをより広範な患者集団のための主要な推奨事項に組み込みつつあります。同時に、世界のトレーニングの取り組みと国境を越えた知識交換が、術者の熟練度と治療の標準化を支えています。治療成績が向上し、利害関係者がデータに裏打ちされた意思決定を求める中、臨床エビデンスは市場成長と機器メーカー間の戦略的差別化の要であり続けると思われます。

大動脈弁市場の成長を促進する要因とは？

大動脈弁市場は、世界の心臓弁膜症の増加、低侵襲的インターベンションの対象拡大、患者中心のエビデンスに基づいた循環器治療への継続的なシフトに後押しされ、力強い成長を遂げています。主な促進要因としては、人口の高齢化、スクリーニングの増加、治療ガイドラインの進化、若年層や低リスク集団におけるTAVRの普及などが挙げられます。外科的治療からカテーテルを用いた治療への移行は、手技の量とアクセシビリティの点で特に大きな変革です。

技術的差別化、長期耐久性、臨床的汎用性は、利害関係者が個別化されたデータ主導の治療経路を求めているため、市場競争力にとって不可欠となっています。一方、市場の拡大は、ハイブリッド手術室、心臓弁専門センター、高度弁治療の訓練を受けた機能横断的な心臓血管チームへの投資の増加によって支えられています。世界の医療システムが効率的で低侵襲かつ価値の高い治療を優先する中、大動脈弁技術は構造的心臓病管理に不可欠なツールとして台頭しつつあります。

今後、大動脈弁市場がどのように進化していくかは、次世代デバイスが多様なヘルスケア環境において性能、耐久性、価格のバランスをいかに効果的にとるかにかかっています。精密心臓病学が低侵襲テクノロジーと融合するにつれ、大動脈弁は、予防的・修復的心臓治療への世界的シフトの中心的ノードとなり得るだろうか。

セグメント

バルブタイプ（機械バルブ、生体バルブ）、エンドユース（病院、外来手術センター、その他のエンドユース）

調査対象企業の例（計34社に注目）

  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Artivion Inc.
  • AutoTissue GmbH
  • Boston Scientific Corporation
  • CarboMedics Inc.
  • Cardiac Dimensions Inc.
  • Cardiosolutions Inc.
  • Corcym Inc.
  • CryoLife Inc.
  • Edwards Lifesciences
  • Endovalve Inc.
  • Foldax Inc.
  • JenaValve Technology Inc.
  • Leman Cardiovascular
  • LivaNova PLC
  • Medtentia AB
  • Medtronic Plc
  • MiCardia Corporation
  • MitralSolutions Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP34610

Global Aortic Valves Market to Reach US$9.8 Billion by 2030

The global market for Aortic Valves estimated at US$6.1 Billion in the year 2024, is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Mechanical Valves, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Biological Valves segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 12.6% CAGR

The Aortic Valves market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 12.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Aortic Valves Market - Key Trends & Drivers Summarized

Why Are Aortic Valves Central to the Management of Structural Heart Disease in Aging Populations?

Aortic valves play a vital role in regulating unidirectional blood flow from the left ventricle to the aorta, and their dysfunction-typically stenosis or regurgitation-leads to significant cardiac morbidity and mortality. Aortic valve replacement (AVR), through either surgical or transcatheter approaches, has become a cornerstone intervention in structural heart disease, particularly among elderly patients with degenerative valve conditions. With the global burden of aortic stenosis rising in parallel with aging demographics, aortic valves are increasingly viewed as life-saving implants for restoring cardiac function, relieving symptoms, and improving survival rates.

Historically, surgical aortic valve replacement (SAVR) was the standard of care, requiring open-heart surgery with cardiopulmonary bypass. However, the advent of transcatheter aortic valve replacement (TAVR)-a minimally invasive approach-has transformed treatment paradigms, expanding access to patients previously deemed inoperable or high-risk for surgery. TAVR’s use has since expanded to intermediate and low-risk groups, reinforcing its role as a first-line therapy across broader patient cohorts. This shift is being fueled by favorable clinical trial data demonstrating comparable or superior outcomes relative to SAVR in appropriate candidates.

Beyond stenosis, aortic valve interventions are gaining ground in the management of bicuspid valve disease, valve-in-valve procedures for degenerated bioprostheses, and combined valvular pathologies requiring multi-valve interventions. The growing prevalence of heart failure, calcific valve degeneration, and increased screening in asymptomatic patients is further driving procedural volume. As life expectancy increases and cardiovascular disease remains a global health priority, aortic valve replacement continues to serve as a critical intervention in contemporary cardiology.

How Are Device Innovations and Procedural Technologies Enhancing Valve Performance and Patient Outcomes?

Innovations in valve design are improving hemodynamic performance, durability, and implantability of both surgical and transcatheter aortic valves. Bioprosthetic valves-constructed from bovine or porcine pericardial tissue-are now treated with anti-calcification agents and mounted on flexible frames to reduce immune response and extend lifespan. New-generation TAVR systems offer repositionable and retrievable features, lower-profile delivery catheters, and enhanced radial strength for secure anchoring, even in anatomically challenging cases such as severely calcified or bicuspid aortic roots.

Advancements in pre-procedural imaging, especially multidetector CT and 3D echocardiography, have enabled more precise patient selection, annular sizing, and procedural planning. Integration of imaging with digital navigation platforms and real-time fluoroscopic guidance has minimized paravalvular leak, vascular injury, and conduction disturbances. In addition, intraprocedural innovations such as cerebral embolic protection devices and conscious sedation protocols are improving safety profiles and enabling shorter recovery times.

Durability remains a central focus of innovation, particularly as younger and lower-risk patients undergo TAVR. Ongoing trials are assessing leaflet longevity, structural valve deterioration, and thrombogenicity to support long-term adoption. Polymer-based leaflet designs, tissue-engineered scaffolds, and anti-thrombotic coatings are being explored to extend valve life beyond current bioprosthetic limits. Meanwhile, efforts to standardize valve-in-valve procedures, optimize hemodynamics in small annuli, and reduce pacemaker dependency are pushing the next frontier in device evolution.

Which Patient Segments and Regional Markets Are Fueling Demand for Aortic Valve Interventions?

The primary drivers of aortic valve replacement remain elderly patients with symptomatic severe aortic stenosis, particularly in North America and Western Europe where diagnostic access, procedural infrastructure, and reimbursement models are well-established. However, the increasing use of echocardiographic screening and growing awareness of heart valve disease are expanding referrals even among asymptomatic patients and moderate-risk groups. TAVR is increasingly preferred for frail patients, those with prior cardiac surgery, and those with anatomical complexities that increase open-surgery risk.

Younger patients and those with bicuspid valves are emerging as an important focus, particularly in markets where average age at diagnosis is lower or where SAVR remains the default due to reimbursement constraints. The valve-in-valve segment is also growing rapidly as the first wave of bioprosthetic implants begins to degenerate. This is creating a new layer of demand for redo TAVR procedures, supported by growing evidence of safety and efficacy in reinterventions.

Geographically, North America holds the largest market share, followed by Europe, driven by high procedural volumes, advanced healthcare infrastructure, and established training ecosystems. Asia-Pacific represents the fastest-growing region due to expanding healthcare access, increasing awareness of valvular heart disease, and rapid growth in private cardiovascular centers across China, India, Japan, and Southeast Asia. Meanwhile, adoption in Latin America, the Middle East, and parts of Africa is supported by public-private partnerships, medical tourism, and growing investment in tertiary cardiovascular care infrastructure.

How Are Regulatory Developments, Value-Based Care Models, and Clinical Evidence Influencing Market Expansion?

The regulatory landscape for aortic valve devices is evolving rapidly, with authorities accelerating approval pathways for TAVR systems through priority review, breakthrough designation, and reliance on global clinical data. Agencies such as the FDA and EMA have expanded device indications from high-risk to intermediate- and low-risk patients, driving broader procedural eligibility and insurance coverage. Post-market surveillance and registries-such as TVT in the U.S. and NOTION in Europe-are providing long-term outcomes data that support ongoing reimbursement and guideline inclusion.

As healthcare systems adopt value-based models, cost-effectiveness and quality-of-life improvements are becoming pivotal to technology adoption. Numerous health economic studies have shown that TAVR, despite higher upfront costs, offers long-term value through reduced rehospitalization, improved functional outcomes, and lower mortality in eligible populations. Hospitals are increasingly selecting valve platforms based on procedure success rates, reintervention risk, and compatibility with evolving treatment protocols across multi-disciplinary heart teams.

Clinical guidelines from societies such as the ESC, AHA/ACC, and JCS are incorporating TAVR into mainstream recommendations for a broader patient population. Simultaneously, global training initiatives and cross-border knowledge exchange are supporting operator proficiency and standardization of care. As procedural outcomes improve and stakeholders demand data-backed decision-making, clinical evidence will remain a cornerstone of market growth and strategic differentiation among device manufacturers.

What Are the Factors Driving Growth in the Aortic Valves Market?

The aortic valves market is experiencing robust growth, fueled by the global rise in valvular heart disease, expanded eligibility for minimally invasive interventions, and the continuous shift toward patient-centered, evidence-based cardiovascular care. Key drivers include aging populations, increased screening, evolving treatment guidelines, and growing comfort with TAVR in younger and lower-risk cohorts. The transition from surgical to catheter-based interventions is particularly transformative in terms of procedural volume and accessibility.

Technological differentiation, long-term durability, and clinical versatility are becoming critical to market competitiveness as stakeholders demand personalized, data-driven care pathways. Meanwhile, market expansion is supported by rising investment in hybrid ORs, specialized heart valve centers, and cross-functional cardiovascular teams trained in advanced valve therapies. As global health systems prioritize efficient, minimally invasive, and high-value care, aortic valve technologies are emerging as essential tools in structural heart disease management.

Looking forward, the evolution of the aortic valves market will depend on how effectively the next generation of devices balances performance, durability, and affordability across diverse healthcare settings. As precision cardiology converges with minimally invasive technologies, could aortic valves represent the central node of a global shift toward preventative and restorative heart care?

SCOPE OF STUDY:

The report analyzes the Aortic Valves market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Valve Type (Mechanical Valves, Biological Valves); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Artivion Inc.
  • AutoTissue GmbH
  • Boston Scientific Corporation
  • CarboMedics Inc.
  • Cardiac Dimensions Inc.
  • Cardiosolutions Inc.
  • Corcym Inc.
  • CryoLife Inc.
  • Edwards Lifesciences
  • Endovalve Inc.
  • Foldax Inc.
  • JenaValve Technology Inc.
  • Leman Cardiovascular
  • LivaNova PLC
  • Medtentia AB
  • Medtronic Plc
  • MiCardia Corporation
  • MitralSolutions Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Aortic Valves - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Aortic Stenosis and Valve Disease Throws the Spotlight on Aortic Valve Replacement
    • Growth in Transcatheter Aortic Valve Replacement (TAVR) Procedures Spurs Minimally Invasive Treatment Demand
    • OEM Innovations in Tissue-Engineered and Self-Expanding Valves Strengthen Market Penetration
    • Increasing Use of Bioprosthetic Valves in Aging Populations Supports Shift Away From Mechanical Alternatives
    • Expansion of Valve-in-Valve Procedures Bodes Well for TAVR in Failed Surgical Valve Replacements
    • Advancements in Imaging-Guided Implantation Improve Procedural Accuracy and Clinical Outcomes
    • Growth in Aortic Valve Clinics and Multidisciplinary Heart Teams Enhances Patient Selection and Preoperative Planning
    • Rise in Early Intervention Guidelines and Lower-Risk Patient Approvals Accelerates Market Growth
    • Integration of AI and Predictive Modeling Supports Personalized Valve Selection and Post-Procedure Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Aortic Valves Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Aortic Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mechanical Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mechanical Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Mechanical Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biological Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biological Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Biological Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Aortic Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Aortic Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Aortic Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Aortic Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION